Personalis, Inc., a leader in advanced genomics for cancer, and ClearNote Health, Inc., a pioneer in epigenomic technologies, unveiled an alliance through which Personalis will...
Invitae, a leading medical genetics company, announced a partnership with BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, designed...
Synthekine Inc., an engineered cytokine therapeutics company, announced a worldwide collaboration with Sanofi to develop and commercialize IL-10 receptor agonists for the treatment of...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
PDS Biotechnology Corporation, a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary...
